Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression.


Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
20 12 2021
Historique:
received: 22 01 2021
revised: 07 06 2021
accepted: 17 06 2021
pubmed: 26 6 2021
medline: 19 2 2022
entrez: 25 6 2021
Statut: ppublish

Résumé

The macrophage theory of depression states that macrophages play an important role in Major Depressive Disorder (MDD). MDD patients (N = 140) and healthy controls (N = 120) participated in a cross-sectional study investigating the expression of apoptosis/growth and lipid/cholesterol pathway genes (BAX, BCL10, EGR1, EGR2, HB-EGF, NR1H3, ABCA1, ABCG1, MVK, CD163, HMOX1) in monocytes (macrophage/microglia precursors). Gene expressions were correlated to a set of previously determined and reported inflammation-regulating genes and analyzed with respect to various clinical parameters. MDD monocytes showed an overexpression of the apoptosis/growth/cholesterol and the TNF genes forming an inter-correlating gene cluster (cluster 3) separate from the previously described inflammation-related gene clusters (containing IL1 and IL6). While upregulation of monocyte gene cluster 3 was a hallmark of monocytes of all MDD patients, upregulation of the inflammation-related clusters was confirmed to be found only in the monocytes of patients with childhood adversity. The latter group also showed a downregulation of the cholesterol metabolism gene MVK, which is known to play an important role in trained immunity and proneness to inflammation. The upregulation of cluster 3 genes in monocytes of all MDD patients suggests a premature aging of the cells, i.e. mitochondrial apoptotic dysfunction and TNF "inflammaging", as a general feature of MDD. The overexpression of the IL-1/IL-6 containing inflammation clusters and the downregulation of MVK in monocytes of patients with childhood adversity indicates a shift in this condition to a more severe inflammation form (pyroptosis) of the cells, additional to the signs of premature aging and inflammaging.

Sections du résumé

BACKGROUND
The macrophage theory of depression states that macrophages play an important role in Major Depressive Disorder (MDD).
METHODS
MDD patients (N = 140) and healthy controls (N = 120) participated in a cross-sectional study investigating the expression of apoptosis/growth and lipid/cholesterol pathway genes (BAX, BCL10, EGR1, EGR2, HB-EGF, NR1H3, ABCA1, ABCG1, MVK, CD163, HMOX1) in monocytes (macrophage/microglia precursors). Gene expressions were correlated to a set of previously determined and reported inflammation-regulating genes and analyzed with respect to various clinical parameters.
RESULTS
MDD monocytes showed an overexpression of the apoptosis/growth/cholesterol and the TNF genes forming an inter-correlating gene cluster (cluster 3) separate from the previously described inflammation-related gene clusters (containing IL1 and IL6). While upregulation of monocyte gene cluster 3 was a hallmark of monocytes of all MDD patients, upregulation of the inflammation-related clusters was confirmed to be found only in the monocytes of patients with childhood adversity. The latter group also showed a downregulation of the cholesterol metabolism gene MVK, which is known to play an important role in trained immunity and proneness to inflammation.
CONCLUSIONS
The upregulation of cluster 3 genes in monocytes of all MDD patients suggests a premature aging of the cells, i.e. mitochondrial apoptotic dysfunction and TNF "inflammaging", as a general feature of MDD. The overexpression of the IL-1/IL-6 containing inflammation clusters and the downregulation of MVK in monocytes of patients with childhood adversity indicates a shift in this condition to a more severe inflammation form (pyroptosis) of the cells, additional to the signs of premature aging and inflammaging.

Identifiants

pubmed: 34171401
pii: S0278-5846(21)00150-0
doi: 10.1016/j.pnpbp.2021.110391
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110391

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Maria S Simon (MS)

Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilians-University, 80336 Munich, Germany. Electronic address: Maria.Simon@med.uni-muenchen.de.

Carmen Schiweck (C)

Department of Neurosciences, Psychiatry Research Group, KUL University of Leuven, Leuven 3000, Belgium.

Gara Arteaga-Henríquez (G)

Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilians-University, 80336 Munich, Germany.

Sara Poletti (S)

Division of Neuroscience, Psychiatry and Clinical Psychobiology Unit, IRCCS San Raffaele Scientific Institute, Milan 20125, Italy.

Bartholomeus C M Haarman (BCM)

Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, Netherlands.

Wim A Dik (WA)

Department of Immunology, Erasmus Medical Center, Rotterdam 3015 GD, Netherlands.

Markus Schwarz (M)

Institute of Laboratory Medicine, University Hospital, Ludwig-Maximilians-University, 81377 Munich, Germany.

Elske Vrieze (E)

Department of Neurosciences, Psychiatry Research Group, KUL University of Leuven, Leuven 3000, Belgium.

Olya Mikova (O)

Foundation Biological Psychiatry, Sofia, Bulgaria.

Silke Joergens (S)

Department of Mental Health, University of Münster, 48149 Münster, Germany.

Richard Musil (R)

Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilians-University, 80336 Munich, Germany.

Stephan Claes (S)

Department of Neurosciences, Psychiatry Research Group, KUL University of Leuven, Leuven 3000, Belgium.

Bernhard T Baune (BT)

Department of Mental Health, University of Münster, 48149 Münster, Germany.

Marion Leboyer (M)

Université Paris Est Créteil, INSERM, IMRB, Translational Neuropsychiatry, F-94010, Créteil, France; AP-HP, Hôpitaux Universitaires H. Mondor, DMU IMPACT, FHU ADAPT, F-94010, Créteil, France.

Francesco Benedetti (F)

Division of Neuroscience, Psychiatry and Clinical Psychobiology Unit, IRCCS San Raffaele Scientific Institute, Milan 20125, Italy.

Roberto Furlan (R)

Clinical Neuroimmunology Unit, Institute of Experimental Neurology, IRCCS Ospedale San Raffaele, Milano 20132, Italy.

Raf Berghmans (R)

Advanced Practical Diagnostics BVBA, Turnhout 2300, Belgium.

Harm de Wit (H)

Department of Immunology, Erasmus Medical Center, Rotterdam 3015 GD, Netherlands.

Annemarie Wijkhuijs (A)

Department of Immunology, Erasmus Medical Center, Rotterdam 3015 GD, Netherlands; RMS, Rotterdam, Netherlands.

Volker Arolt (V)

Department of Mental Health, University of Münster, 48149 Münster, Germany.

Norbert Müller (N)

Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilians-University, 80336 Munich, Germany.

Hemmo A Drexhage (HA)

Department of Immunology, Erasmus Medical Center, Rotterdam 3015 GD, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH